Show simple item record

dc.contributor.authorAngela O.Achienga, Bernard Guyah,Qiuying Cheng,John M.Ong'echa,Collins Ouma,Christophe G.Lambert,Douglas J.Perkins
dc.date.accessioned2022-02-18T08:39:20Z
dc.date.available2022-02-18T08:39:20Z
dc.date.issued2019
dc.identifier.urihttps://repository.maseno.ac.ke/handle/123456789/5007
dc.descriptionhttps://doi.org/10.1016/j.ebiom.2019.06.040en_US
dc.description.abstractLeukocyte-associated immunoglobulin like receptor-1 (LAIR1) is a transmembrane inhibitory receptor that influences susceptibility to a myriad of inflammatory diseases. Our recent investigations of severe malarial anaemia (SMA) pathogenesis in Kenyan children discovered that novel LAIR1 genetic variants which were associated with decreased LAIR1 transcripts enhanced the longitudinal risk of SMA and all-cause mortality.en_US
dc.publisherscience directen_US
dc.subjectComplement component 1qLeukocyte-associated immunoglobulin like receptor-1Leukocyte-associated immunoglobulin like receptor-2Plasmodium falciparum malariaPlasmodium falciparum haemozoinSevere malarial anaemiaen_US
dc.titleMolecular basis of reduced LAIR1 expression in childhood severe malarial anaemia: Implications for leukocyte inhibitory signallingen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record